ArticleFrontiers in pharmacology2024

Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

Dong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.